Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Clinical Significance of Histological Effect and Intratumor Stromal Expression of Tenascin-C in Resected Specimens After Chemoradiotherapy for Initially Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma.

Hayasaki A, Murata Y, Usui M, Hibi T, Ito T, Iizawa Y, Kato H, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Yoshida T, Isaji S.

Pancreas. 2018 Apr;47(4):390-399. doi: 10.1097/MPA.0000000000001022.

PMID:
29517632
2.

Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer.

Hayasaki A, Isaji S, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Mizuno S, Usui M, Sakurai H.

Cancers (Basel). 2018 Mar 5;10(3). pii: E65. doi: 10.3390/cancers10030065.

3.

Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis.

Shitaoka K, Hamana H, Kishi H, Hayakawa Y, Kobayashi E, Sukegawa K, Piao X, Lyu F, Nagata T, Sugiyama D, Nishikawa H, Tanemura A, Katayama I, Murahashi M, Takamatsu Y, Tani K, Ozawa T, Muraguchi A.

Cancer Immunol Res. 2018 Apr;6(4):378-388. doi: 10.1158/2326-6066.CIR-17-0489. Epub 2018 Feb 23.

PMID:
29475880
4.

Clinical response to PD-1 blockade correlates with a sub-fraction of peripheral central memory CD4+ T cells in patients with malignant melanoma.

Takeuchi Y, Tanemura A, Tada Y, Katayama I, Kumanogoh A, Nishikawa H.

Int Immunol. 2018 Feb 3;30(1):13-22. doi: 10.1093/intimm/dxx073.

PMID:
29294043
5.

Dysregulation of autophagy in melanocytes contributes to hypopigmented macules in tuberous sclerosis complex.

Yang F, Yang L, Wataya-Kaneda M, Hasegawa J, Yoshimori T, Tanemura A, Tsuruta D, Katayama I.

J Dermatol Sci. 2018 Feb;89(2):155-164. doi: 10.1016/j.jdermsci.2017.11.002. Epub 2017 Nov 11.

PMID:
29146131
6.

Uncoupling of ER/Mitochondrial Oxidative Stress in mTORC1 Hyperactivation-Associated Skin Hypopigmentation.

Yang F, Yang L, Wataya-Kaneda M, Yoshimura T, Tanemura A, Katayama I.

J Invest Dermatol. 2018 Mar;138(3):669-678. doi: 10.1016/j.jid.2017.10.007. Epub 2017 Dec 6.

PMID:
29080681
7.

Platelet Activation Assessed by Glycoprotein VI/Platelet Ratio Is Associated With Portal Vein Thrombosis After Hepatectomy and Splenectomy in Patients With Liver Cirrhosis.

Matsui T, Usui M, Wada H, Iizawa Y, Kato H, Tanemura A, Murata Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Isaji S.

Clin Appl Thromb Hemost. 2018 Mar;24(2):254-262. doi: 10.1177/1076029617725600. Epub 2017 Oct 19.

PMID:
29050501
8.

Long-term outcomes after pancreaticoduodenectomy using pair-watch suturing technique: Different roles of pancreatic duct dilatation and remnant pancreatic volume for the development of pancreatic endocrine and exocrine dysfunction.

Iizawa Y, Kato H, Kishiwada M, Hayasaki A, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Mizuno S, Usui M, Sakurai H, Isaji S.

Pancreatology. 2017 Sep - Oct;17(5):814-821. doi: 10.1016/j.pan.2017.06.008. Epub 2017 Jun 23.

9.

Three-dimensional cell shapes and arrangements in human sweat glands as revealed by whole-mount immunostaining.

Kurata R, Futaki S, Nakano I, Fujita F, Tanemura A, Murota H, Katayama I, Okada F, Sekiguchi K.

PLoS One. 2017 Jun 21;12(6):e0178709. doi: 10.1371/journal.pone.0178709. eCollection 2017.

10.

Physician-initiated first-in-human clinical study using a novel angiogenic peptide, AG30/5C, for patients with severe limb ulcers.

Nakagami H, Yamaoka T, Hayashi M, Tanemura A, Takeya Y, Kurinami H, Sugimoto K, Nakamura A, Tomono K, Tamai K, Katayama I, Rakugi H, Kaneda Y.

Geriatr Gerontol Int. 2017 Nov;17(11):2150-2156. doi: 10.1111/ggi.13051. Epub 2017 May 10.

PMID:
28488306
11.

Superiority of stapled side-to-side gastrojejunostomy over conventional hand-sewn end-to-side gastrojejunostomy for reducing the risk of primary delayed gastric emptying after subtotal stomach-preserving pancreaticoduodenectomy.

Murata Y, Tanemura A, Kato H, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S.

Surg Today. 2017 Aug;47(8):1007-1017. doi: 10.1007/s00595-017-1504-z. Epub 2017 Mar 23.

12.

Pretransplant Serum Hyaluronic Acid Can Be a Biomarker as a Prognostic Predictor in Adult-to-Adult Living Donor Liver Transplantation.

Mizuno S, Das BC, Iizawa Y, Kato H, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S.

Transplant Proc. 2017 Jan - Feb;49(1):102-108. doi: 10.1016/j.transproceed.2016.11.019.

PMID:
28104115
13.

Transhepatic Hilar Approach for Perihilar Cholangiocarcinoma: Significance of Early Judgment of Resectability and Safe Vascular Reconstruction.

Kuriyama N, Isaji S, Tanemura A, Iizawa Y, Kato H, Murata Y, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H.

J Gastrointest Surg. 2017 Mar;21(3):590-599. doi: 10.1007/s11605-016-3332-7. Epub 2016 Nov 28.

14.

Negative Impact of Biliary Candidiasis on Early and Late Postoperative Complications After Pancreatoduodenectomy Usefulness of the CHROMagar Candida Plate for Identification.

Kato H, Iizawa Y, Kishiwada M, Usui M, Nakamura A, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Mizuno S, Sakurai H, Isaji S.

Pancreas. 2016 Oct;45(9):e45-7. doi: 10.1097/MPA.0000000000000682. No abstract available.

PMID:
27623557
15.

A Novel Predictor of Posttransplant Portal Hypertension in Adult-To-Adult Living Donor Liver Transplantation: Increased Estimated Spleen/Graft Volume Ratio.

Gyoten K, Mizuno S, Kato H, Murata Y, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Usui M, Sakurai H, Isaji S.

Transplantation. 2016 Oct;100(10):2138-45. doi: 10.1097/TP.0000000000001370.

16.

Critical renal adverse event induced by nivolumab therapy in a stage IV melanoma patient.

Tanaka A, Ikinaga K, Kiyohara E, Tanemura A, Wataya-Kaneda M, Fujimura R, Mizui M, Isaka Y, Katayama I.

J Dermatol. 2017 Jun;44(6):727-728. doi: 10.1111/1346-8138.13538. Epub 2016 Jul 27. No abstract available.

PMID:
27461931
17.

Impact of Splenectomy Just Before Partial Orthotopic Liver Transplantation Using Small-for-Size Graft in Rats.

Kuriyama N, Iizawa Y, Kato H, Murata Y, Tanemura A, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S.

Transplant Proc. 2016 May;48(4):1304-8. doi: 10.1016/j.transproceed.2016.02.041. Erratum in: Transplant Proc. 2017 May;49(4):916.

PMID:
27320610
18.

Living Donor Liver Transplantation for Biliary Atresia With Severe Preduodenal Portal Vein Stricture: Success and Pitfall of Portal Vein Reconstruction.

Kato H, Usui M, Iizawa Y, Tanemura A, Murata Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Inoue M, Uchida K, Isaji S.

Transplant Proc. 2016 May;48(4):1218-20. doi: 10.1016/j.transproceed.2016.01.029.

PMID:
27320591
19.

Influence of Angiotensin-converting Enzyme Genetic Polymorphism on Late Renal Dysfunction After Adult-to-adult Living-donor Liver Transplantation.

Matsui T, Usui M, Fujinaga K, Nakatani K, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Isaji S.

Transplant Proc. 2016 May;48(4):1184-9. doi: 10.1016/j.transproceed.2016.02.014.

PMID:
27320583
20.

Discontinuation of Hepatitis B Immunoglobulin by Long-term Hepatitis B Vaccine Inoculation in Preventing Hepatitis B Recurrence After Liver Transplantation.

Usui M, Sugimoto K, Kato H, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Takei Y, Isaji S.

Transplant Proc. 2016 May;48(4):1179-83. doi: 10.1016/j.transproceed.2015.12.110.

PMID:
27320582
21.

Technical Feasibility and Clinical Outcomes of Interventional Endovascular Treatment for Hepatic Artery Thrombosis After Living-donor Liver Transplantation.

Murata Y, Mizuno S, Kato H, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Fujimori M, Yamanaka T, Nakatsuka A, Yamakado K, Isaji S.

Transplant Proc. 2016 May;48(4):1142-8. doi: 10.1016/j.transproceed.2015.12.092.

PMID:
27320575
22.

Long-Term Influence of CYP3A5 Gene Polymorphism on Pharmacokinetics of Tacrolimus and Patient Outcome After Living Donor Liver Transplantation.

Kato H, Usui M, Muraki Y, Tanemura A, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Okuda M, Nakatani K, Isaji S.

Transplant Proc. 2016 May;48(4):1087-94. doi: 10.1016/j.transproceed.2016.02.012.

PMID:
27320564
23.

D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.

Tanemura A, Mizuno S, Kato H, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S.

Transplant Proc. 2016 May;48(4):1025-31. doi: 10.1016/j.transproceed.2015.12.090.

PMID:
27320548
24.

The effect of rhododendrol inhibition of NF-κB on melanocytes in the presence of tyrosinase.

Arase N, Yang L, Tanemura A, Yang F, Suenaga T, Arase H, Katayama I.

J Dermatol Sci. 2016 Aug;83(2):157-9. doi: 10.1016/j.jdermsci.2016.05.002. Epub 2016 May 3. No abstract available.

PMID:
27174091
25.

Comparative Study on the Cytoprotective Effects of Activated Protein C Treatment in Nonsteatotic and Steatotic Livers under Ischemia-Reperfusion Injury.

Matsuda A, Kuriyama N, Kato H, Tanemura A, Murata Y, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S.

Biomed Res Int. 2015;2015:635041. doi: 10.1155/2015/635041. Epub 2015 Oct 11.

26.

Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cells.

Tagami-Nagata N, Serada S, Fujimoto M, Tanemura A, Nakatsuka R, Ohkawara T, Murota H, Kishimoto T, Katayama I, Naka T.

Exp Dermatol. 2015 Nov;24(11):864-71. doi: 10.1111/exd.12802. Epub 2015 Sep 3.

PMID:
26173926
27.

A rare case of mucinous carcinoma of the skin with multiple organ metastases.

Tanemura A, Deguchi A, Tanaka A, Kiyohara E, Kishioka A, Katayama I.

Eur J Dermatol. 2015 Sep-Oct;25(5):483-4. doi: 10.1684/ejd.2015.2545. No abstract available.

PMID:
25906438
28.

Spontaneous Rupture of an Intrasplenic Aneurysm After Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma.

Mizuno S, Imai H, Takaki H, Tanemura A, Kuriyama N, Sakurai H, Yamakado K, Sakuma H, Isaji S.

J Emerg Med. 2015 Jun;48(6):729-30. doi: 10.1016/j.jemermed.2014.11.025. Epub 2015 Apr 11. No abstract available.

PMID:
25869140
29.

NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation.

Namiki T, Yaguchi T, Nakamura K, Valencia JC, Coelho SG, Yin L, Kawaguchi M, Vieira WD, Kaneko Y, Tanemura A, Katayama I, Yokozeki H, Kawakami Y, Hearing VJ.

Cancer Res. 2015 Jul 1;75(13):2708-15. doi: 10.1158/0008-5472.CAN-13-3209. Epub 2015 Apr 1.

30.

Possible involvement of CCR4+ CD8+ T cells and elevated plasma CCL22 and CCL17 in patients with rhododenol-induced leukoderma.

Nishioka M, Tanemura A, Yang L, Tanaka A, Arase N, Katayama I.

J Dermatol Sci. 2015 Mar;77(3):188-90. doi: 10.1016/j.jdermsci.2015.02.014. Epub 2015 Mar 3. No abstract available.

PMID:
25766765
31.

Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex.

Wataya-Kaneda M, Tanaka M, Yang L, Yang F, Tsuruta D, Nakamura A, Matsumoto S, Hamasaki T, Tanemura A, Katayama I.

JAMA Dermatol. 2015 Jul;151(7):722-30. doi: 10.1001/jamadermatol.2014.4298.

PMID:
25692384
32.

4-(4-hydroroxyphenyl)-2-butanol (rhododendrol) activates the autophagy-lysosome pathway in melanocytes: insights into the mechanisms of rhododendrol-induced leukoderma.

Yang L, Yang F, Wataya-Kaneda M, Tanemura A, Tsuruta D, Katayama I.

J Dermatol Sci. 2015 Mar;77(3):182-5. doi: 10.1016/j.jdermsci.2015.01.006. Epub 2015 Jan 28. No abstract available.

PMID:
25680854
33.

An immune pathological and ultrastructural skin analysis for rhododenol-induced leukoderma patients.

Tanemura A, Yang L, Yang F, Nagata Y, Wataya-Kaneda M, Fukai K, Tsuruta D, Ohe R, Yamakawa M, Suzuki T, Katayama I.

J Dermatol Sci. 2015 Mar;77(3):185-8. doi: 10.1016/j.jdermsci.2015.01.002. Epub 2015 Jan 24.

PMID:
25676426
34.

Major association of vitiligo with HLA-A*02:01 in Japanese.

Jin Y, Hayashi M, Fain PR, Suzuki T, Fukai K, Oiso N, Tanemura A, Holcomb CL, Rastrou M, Erlich HA, Spritz RA.

Pigment Cell Melanoma Res. 2015 May;28(3):360-2. doi: 10.1111/pcmr.12356. Epub 2015 Feb 17. No abstract available.

35.

Guide for medical professionals (i.e., dermatologists) for the management of Rhododenol-induced leukoderma.

Nishigori C, Aoyama Y, Ito A, Suzuki K, Suzuki T, Tanemura A, Ito M, Katayama I, Oiso N, Kagohashi Y, Sugiura S, Fukai K, Funasaka Y, Yamashita T, Matsunaga K.

J Dermatol. 2015 Feb;42(2):113-28. doi: 10.1111/1346-8138.12744.

PMID:
25622988
36.

Severe scoliosis associated with the WNT10A mutation.

Koguchi-Yoshioka H, Wataya-Kaneda M, Nakano H, Tanemura A, Akasaka E, Sawamura D, Katayama I.

J Dermatol. 2015 Mar;42(3):322-3. doi: 10.1111/1346-8138.12762. Epub 2015 Jan 9. No abstract available.

PMID:
25571904
37.

Transient wheal attack corresponding to the tumor lesions of primary cutaneous diffuse large B cell lymphoma, leg type after successive rituximab treatment.

Itoi S, Tanemura A, Hayashi M, Nagata N, Tani M, Katayama I.

Case Rep Dermatol. 2014 Sep 11;6(3):218-21. doi: 10.1159/000367936. eCollection 2014 Sep.

38.

Pigmented epithelioid melanocytoma with lymph node metastasis in a patient with uncontrolled atopic dermatitis.

Hayashi M, Tanemura A, Matsuda K, Hosokawa K, Izumi M, Ohara K, Mihm MC, Katayama I.

J Dermatol. 2014 Nov;41(11):1023-5. doi: 10.1111/1346-8138.12631. Epub 2014 Oct 8. No abstract available.

PMID:
25294720
39.

Isolation and characterization of sweat gland myoepithelial cells from human skin.

Kurata R, Futaki S, Nakano I, Tanemura A, Murota H, Katayama I, Sekiguchi K.

Cell Struct Funct. 2014;39(2):101-12. Epub 2014 Sep 5.

40.

Development of necrotising fasciitis in a patient treated for rheumatoid arthritis with tocilizumab.

Hashimoto N, Yamaoka T, Koguchi-Yoshioka H, Tanaka A, Tanemura A, Azukizawa H, Murota H, Kang J, Nakagawa Y, Shimazu T, Katayama I.

Acta Derm Venereol. 2015 Mar;95(3):370-1. doi: 10.2340/00015555-1952. No abstract available.

41.

Anti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer.

Yamaoka T, Doi C, Yokomi A, Tanemura A, Murota H, Tani M, Saruban H, Hamaguchi Y, Fujimoto M, Katayama I.

Eur J Dermatol. 2014 Jul-Aug;24(4):490-1. doi: 10.1684/ejd.2014.2381. No abstract available.

PMID:
25075604
42.

A new surgical technique of pancreaticoduodenectomy with splenic artery resection for ductal adenocarcinoma of the pancreatic head and/or body invading splenic artery: impact of the balance between surgical radicality and QOL to avoid total pancreatectomy.

Desaki R, Mizuno S, Tanemura A, Kishiwada M, Murata Y, Azumi Y, Kuriyama N, Usui M, Sakurai H, Tabata M, Isaji S.

Biomed Res Int. 2014;2014:219038. doi: 10.1155/2014/219038. Epub 2014 Jun 12.

43.

Immunohistochemical Analysis of Interleukin-17 Producing T Helper Cells and Regulatory T Cells Infiltration in Annular Erythema Associated with Sjögren's Syndrome.

Itoi S, Tanemura A, Tani M, Kitaba S, Terao M, Murota H, Oiso N, Katayama I.

Ann Dermatol. 2014 Apr;26(2):203-8. doi: 10.5021/ad.2014.26.2.203. Epub 2014 Apr 30.

44.

Thrombomodulin administration attenuates ischemia-reperfusion injury of the remnant liver after 70% hepatectomy in rats: simulated model of small-for-size graft in living donor liver transplantation.

Tanemura A, Kuriyama N, Azumi Y, Ohsawa I, Kishiwada M, Mizuno S, Usui M, Sakurai H, Tabata M, Isaji S.

Transplant Proc. 2014 May;46(4):1107-11. doi: 10.1016/j.transproceed.2013.11.128.

PMID:
24815140
45.

[Studies on the distribution of doripenem in pancreatic tissues, especially on the importance of the ratio in pancreatic tissue concentration of doripenem/serum concentration of doripenem].

Nobuoka Y, Tanemura A, Azumi Y, Kishiwada M, Osawa I, Mizuno S, Usui M, Sakurai H, Tabata M, Isaji S.

Jpn J Antibiot. 2014 Feb;67(1):15-21. Japanese.

PMID:
24809205
46.

Biliary complications in 108 consecutive recipients with duct-to-duct biliary reconstruction in living-donor liver transplantation.

Mizuno S, Inoue H, Tanemura A, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamada R, Yamamoto N, Sugimoto K, Shiraki K, Takei Y, Isaji S.

Transplant Proc. 2014 Apr;46(3):850-5. doi: 10.1016/j.transproceed.2013.11.035.

PMID:
24767364
47.

Negative prognostic impact of renal replacement therapy in adult living-donor liver transplant recipients: preoperative recipient condition and donor factors.

Iwata H, Mizuno S, Ishikawa E, Tanemura A, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamamoto N, Sugimoto K, Shiraki K, Takei Y, Ito M, Isaji S.

Transplant Proc. 2014 Apr;46(3):716-20. doi: 10.1016/j.transproceed.2013.11.113.

PMID:
24767332
48.

Severe gangrene accompanied by varicella zoster virus-related vasculitis mimicking rheumatoid vasculitis.

Tanaka A, Hayaishi N, Kondo Y, Kurachi K, Tanemura A, Katayama I.

Case Rep Dermatol. 2014 Mar 21;6(1):103-7. doi: 10.1159/000360979. eCollection 2014 Jan.

49.

A rare case of male bullous lupus erythematosus complicated with subsequent annular hypopigmentation.

Itoi S, Tanemura A, Tsuji C, Kitaba S, Yokomi A, Katayama I, Tateishi C, Tsuruta D.

Case Rep Dermatol. 2014 Mar 19;6(1):91-7. doi: 10.1159/000360980. eCollection 2014 Jan.

50.

Clinicopathological factors affecting survival and recurrence after initial hepatectomy in non-B non-C hepatocellular carcinoma patients with comparison to hepatitis B or C virus.

Okuda Y, Mizuno S, Shiraishi T, Murata Y, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamada T, Isaji S.

Biomed Res Int. 2014;2014:975380. doi: 10.1155/2014/975380. Epub 2014 Mar 13.

Supplemental Content

Loading ...
Support Center